Stephen Moore, 54, who has served as a firefighter in London for 23 years, is attempting to run the fastest marathon wearing ...

More than 46,000 people will start the TCS London Marathon on Sunday with 87 different world record attempts taking place on ...

The Golden State Warriors faced off against the Memphis Grizzlies in a crunch class on Tuesday, and won in an epic fashion. Despite winning, the NBA community baffled everyone with the ‘poor ...

The NBA acknowledged on Wednesday a number of officiating errors late in the Golden State Warriors' 121-116 win over the Memphis Grizzles in a Western Conference play-in game on Tuesday night in ...

Officials made multiple errors in the final two minutes of the Grizzlies-Warriors play-in game on April 15, the NBA said in its last two minute report. The refs made four errors in the final two ...

The Golden State Warriors had arguably their worst loss of the season against the San Antonio Spurs on Wednesday night. In what was a must-win game, the Warriors fell to a very shorthanded Spurs team.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

I remember the day of my relapsing-remitting multiple sclerosis diagnosis, when I didn’t understand the weight of what I’d been told. I was only 17 years old and didn’t know what questions ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of Neurology 2025 annual meeting. Links to each presentation are included below. Michael S. Weiss, Chief ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

While topline results of HERCULES were first presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting last September, the peer-reviewed paper offers ...